Results 61 to 70 of about 819,276 (191)

An insight into the therapeutic potential of quinazoline derivatives as anticancer agents

open access: yes, 2017
This article reviews the recent advances in the development of quinazoline derivatives as anticancer agents.
Irshad Ahmad, Shagufta Shagufta
core   +1 more source

Acid‐Free, Room‐Temperature Carbamoylations of Heteroaromatics With N‐Substituted Formamides via TBADT Catalysis and Hydrogen Bonding

open access: yesChemistry–Methods, Volume 6, Issue 11, November 2026.
TBAB boost the TBADT catalyzed carbamoylations of heteroaromatics with N‐substituted formamides through halogen─hydrogen bonding network. TBADT‐catalyzed carbamoylation under heat‐free neutral conditions has been reported. Unlike conventional reports, the addition of TBAB, which could promote the TBADT catalytic system via bromide─hydrogen bonding ...
Ziheng Yu   +8 more
wiley   +1 more source

Pharmacokinetic and Pharmacodynamic Interactions Between Anti‐Asthma Drugs and Medicinal Plants: A Comprehensive Review

open access: yesPhytotherapy Research, Volume 40, Issue 11, Page 6418-6449, November 2026.
ABSTRACT Asthma affects 260–300 million people worldwide. About 20%–35% of patients use medicinal plants with their asthma medication, often without telling their clinicians. Disclosure rates are low; up to 42% of asthma outpatients use herbal products, with no records in their charts.
Emine Kocyigit   +5 more
wiley   +1 more source

Synthesis and characterization of some new 4-heteroaryl quinazoline and fused triazolo quinazoline derivatives

open access: yes, 2016
Treatment of chloroquinazoline (2) with primary amines (2-aminothiazoles and sulpha drugs) and secondary amines (morpholine, piperidine, and piperazine) furnished 4-substituted aminoquinazolines (3a,b and 4a,b), 4-aryl quinazolines (5a,b), and ...
El-Badry, Yaser Abdel-Moemen   +2 more
core   +1 more source

Covalent drug discovery: Progress against key targets, emerging strategies and lessons learnt

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 22, Page 6574-6606, November 2026.
Abstract Covalent drug discovery is currently experiencing a boom in industrial and academic interest. To date, at least 75 covalent drugs have received regulatory approval, targeting both traditional target classes and more challenging proteins for which other approaches failed. In many cases, unique aspects of covalent targeting are essential for the
Charles P. Brown   +2 more
wiley   +1 more source

Synthesis of Quinazoline Derivatives

open access: yes
Efficient synthesis of heterocyclic has always been a very important task in drug discovery. Most of the drugs contain heterocycles to provide an interface between chemistry and biology.
Yadav, Anjali   +5 more
core   +1 more source

Synthesis of Nitrogen‐Containing Heterocyclic Scaffolds and Applications in Scaffold Hopping: Development of an Aripiprazole Analog

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
A series of 12 novel fused [6,6] saturated and unsaturated nitrogen bicycles is synthesized in three to five steps and expands the CRAFT library's fragment space. A 2,6‐naphthyridin‐3‐ol core replaces the dihydroquinolinone scaffold of aripiprazole, a scaffold‐hopping strategy.
Temitayo Omowumi Alegbejo Price   +12 more
wiley   +1 more source

Exploring Quinazoline Nitro-Derivatives as Potential Antichagasic Agents: Synthesis and In Vitro Evaluation

open access: yesMolecules
Trypanosoma cruzi is a protozoan parasite that causes Chagas disease in humans. The current antichagasic drugs nifurtimox and benznidazole have inconveniences of toxicity; therefore, the search for alternative therapeutic strategies is necessary.
Citlali Vázquez   +7 more
doaj   +1 more source

The significance of quinazoline derivatives as potential multi-target anti-cancer agents: review article [PDF]

open access: yesJournal of Advanced Biomedical and Pharmaceutical Sciences
In recent years, the use of quinazoline and its derivatives as structural scaffolds has shown significant promise in drug design. These compounds have shown significant biological efficacy in the treatment of a variety of diseases, including cancer ...
Mostafa Mansour   +4 more
doaj   +1 more source

Tuning the Triazolotriazine Scaffold Toward Selective A3 Adenosine Receptor Antagonists: From Molecular Recognition to Neuroprotection

open access: yesChemMedChem, Volume 21, Issue 20, 28 October 2026.
Structure‐based optimization of the triazolo‐triazine scaffold afforded highly potent and selective adenosine A3 receptor antagonists. Replacement of the classical 2‐furyl group with phenyl‐based substituents markedly improved A3 receptor affinity and selectivity.
Veronika Kost   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy